Additionally, metformin-induced AMPK signaling converges at FOXO3 to stimulate SETD2 expression, subsequently enhancing its substrate EZH2’s enhancer to delay PCa metastasis. The gene discussed is EZH2; the disease is posterior cortical atrophy.